4.8 Letter

Will patient-centric sampling become the norm for clinical trials after COVID-19?

Journal

NATURE MEDICINE
Volume 26, Issue 12, Pages 1810-1810

Publisher

NATURE RESEARCH
DOI: 10.1038/s41591-020-01144-1

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available